Syringe Needle Market

Growing vaccination need is driving the market growth

The rising vaccination need drives Market CAGR for syringe and needle. Recently, there has been an increase in the need for the production of syringes and needles. As a result, it constitutes one of the primary drivers of this industry. Aside from that, tremendous technical improvements inside the twenty-three-inch syringe and needle drug injection equipment are propelling this industry to new heights. Furthermore, as injectable medications are superior to oral treatments, their demand is constantly growing.

Moreover, Organizations are learning about them from beginning to end distribution networks to lower the cost of goods while improving the standard of goods and amenities related to disposable syringes. These operational approaches assist organizations in saving money by avoiding third-party costs. These qualities are expected to provide profitable market growth opportunities.

The COVID had little impact on the medical supply business. The healthcare and medical equipment sectors worked harder than normal. However, the industrial speed was slowed as the workforce deteriorated throughout that time frame. Producers have increased their syringe and needles manufacturing facilities to increase the supply of the COVID-19 vaccine. The growing involvement of community members and chemists in chronic disease management and an emphasis on drug adherence during the COVID-19 pandemic has reduced the strain on healthcare systems.

For example, the US government has entered into a USD 138 million agreement with key syringe makers to expedite the production of one hundred million needles for COVID-19 vaccinations.

For instance, based on the GLOBOCAN 2020 estimate, the overall number of cancer-related cases in the globe in 2020 would be about 19,292,789 occurrences. The total amount of cases will increase to 28,887,940 through 2040. The increasing incidence of cancer cases causes a need for needles and syringes for medication administration, contributing considerably to the market's growth during the projected timeframe. Therefore, it is expected that throughout the projected timeframe, demand for syringes and Needles will increase due to the rising vaccination need. Thus, driving the Syringe and Needle market revenue.

The Global Syringe and Needle Market Industry experiences a notable surge in demand for vaccination initiatives. As governments worldwide prioritize immunization programs, the need for syringes and needles escalates. For instance, the World Health Organization emphasizes the importance of vaccination in controlling infectious diseases, leading to increased procurement of these medical devices. In 2024, the market is projected to reach 9.85 USD Billion, reflecting the growing emphasis on public health. This trend is expected to continue, with the market anticipated to expand significantly by 2035, reaching 17.1 USD Billion, as vaccination efforts remain a global priority.

The expansion of healthcare infrastructure in emerging economies significantly impacts the Global Syringe and Needle Market Industry. Governments are investing in healthcare facilities to improve access to medical services, particularly in rural and underserved areas. This expansion often includes the procurement of essential medical supplies, including syringes and needles. As healthcare systems evolve, the demand for these devices is expected to rise, contributing to the overall market growth. The increasing number of healthcare facilities and the emphasis on improving patient care are likely to drive the market forward, reflecting a broader commitment to enhancing health outcomes globally.

The Global Syringe and Needle Market Industry is significantly influenced by the rising prevalence of chronic diseases, such as diabetes and cardiovascular conditions. According to health statistics, the global burden of chronic diseases continues to escalate, necessitating regular medical interventions. This trend drives the demand for syringes and needles, particularly for insulin delivery and other injectable therapies. As healthcare systems adapt to manage these conditions more effectively, the market is projected to grow at a CAGR of 5.17% from 2025 to 2035. This growth trajectory underscores the critical role of syringes and needles in the ongoing management of chronic health issues.

Technological innovations play a crucial role in shaping the Global Syringe and Needle Market Industry. The introduction of safety-engineered syringes, which minimize the risk of needlestick injuries, is a prime example of how advancements enhance safety and efficiency in healthcare settings. Moreover, the integration of smart technologies, such as needle-free injection systems, is gaining traction. These innovations not only improve patient comfort but also streamline the administration of medications. As healthcare providers increasingly adopt these advanced solutions, the market is likely to witness sustained growth, driven by the demand for safer and more efficient medical devices.

Regulatory frameworks promoting safe injection practices are pivotal in shaping the Global Syringe and Needle Market Industry. Governments and health organizations advocate for stringent regulations to minimize the risk of infections and ensure patient safety. Initiatives aimed at standardizing syringe and needle usage, along with guidelines for their disposal, are gaining traction. This regulatory support not only enhances the safety of medical procedures but also fosters confidence among healthcare providers and patients. As these regulations become more widespread, the demand for compliant syringes and needles is likely to increase, further propelling market growth.

By region, the research provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American Syringe and Needle market area is estimated to grow rapidly during the projected timeframe, owing to an increase in cardiac problems and diabetes leading to the development of innovation in syringes and needles products. In addition, the growing number of diseases prevalence in the North American region will boost the market growth.

Further, the major countries studied in the market report are the US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: Syringe and Needle Market Share by Region 2022 (USD Billion) 

Source: Secondary Research, Primary Research, Market Research Future Database, and Analyst Review

Europe region’s Syringe and Needle market will dominate due to increasing need and demand for syringes and needles sales, generating higher revenue during the projected timeframe. Further, the German Syringe and Needle market dominates the market share, and the UK Syringe and Needle market is anticipated to expand quickly in the European region.

The Asia-Pacific Syringe and Needle Market accounts for the second-highest market share during the projected timeframe. This is due to several government programs aimed at encouraging the utilization of disposable healthcare products to reduce transmission, along with the existence of important market players in the region, which are anticipated to enhance the market growth in the APAC region. Moreover, China’s Syringe and Needle market holds the largest market share, and the Indian Syringe and Needle market is anticipated to grow in the Asia-Pacific region during the projected timeframe.

Leading market players invested heavily in research and development (R&D) to scale up their manufacturing units and product lines, which will help the Syringe and Needle market grow worldwide. Market participants are also undertaking various organic or inorganic strategic approaches to strengthen and expand their footprint, with important market developments including new product portfolios, contractual deals, mergers and acquisitions, capital expenditure, higher investments, and strategic alliances with other organizations. Businesses are also coming up with marketing strategies such as digital marketing, social media influencing, and content marketing to increase their scope of profit earnings.

The Syringe and Needle industry must offer cost-effective and sustainable options to survive in a dynamic market.

Manufacturing locally to minimize operational expenses is a key business strategy manufacturers use in the Syringe and Needle industry to benefit customers and capture untapped market share and revenue. The Syringe and Needle industry has recently offered significant advantages to the medicine and service industry. Major players in the Syringe and Needle market, including DeRoyal, Albert David Ltd, B. Braun Melsungen AG, Terumo Corporation, Connecticut Hypodermics Inc., Insulet, Septodont, Medtronic, BD, Schott AG, Cardinal Health, and Smiths Medical, are attempting to expand market share and demand by investing in research and development (R&D) operations to produce sustainable and affordable solutions.

WuXi Biologics, From concept through the product's commercial, is now a truly worldwide single-source pharmaceutical technology platform. It was founded in 2010 and began developing the expertise and infrastructure needed for biologics research and development (R&D) and GMP manufacture. In June 2017, it got listed on the Hong Kong Stock Exchange. Wuxi Biologics, a contractual research and development (R&D) and production organization (CRDMO) began Exemplary Production practice operations at its newly constructed pharma product factory DP5 in Wuxi (China) in June 2022. With already-filled syringes, the factory provides many volume delivery choices.

HTL STREFA is an international company with over 80 years of expertise. They are the world's top provider of blood micro-sampling instruments for medicine. It is devoted to producing safeguards that reduce or eradicate the danger of blood-borne infections. They use an ongoing improvement method to analyze and upgrade goods, develop changes, and introduce novel approaches in response to evolving patient and medical professional demands. They strive to meet the most stringent sanitary and sterile requirements. Their manufacturing process is characterized by ergonomics, which is simplicity and dependability.

HTL-STREFA announced Droplet MicronTM on the 22nd of September 2020 as an updated needle and syringe with an improved design that will enhance the process of injection experience.